How Targeted Therapies Are Driving the Global Kinase Inhibitors Market
The global Kinase Inhibitors Market is witnessing steady expansion as targeted therapies continue to reshape modern healthcare. Valued at US$ 58,090.1 Mn in 2023, the market is projected to reach US$ 89,929.8 Mn by 2034, growing at a CAGR of 3.9% from 2024 to 2034. Rising cancer prevalence, continuous innovation in targeted therapies, and increasing adoption of personalized medicine are the...
Amit Mohite
2026-07-29 09:40:38